← All companies
NovoCure Ltd
NVCR - CIK 0001645113
Market cap$1.93 B
Rank#2120
SEC filings1,138
The table below shows NovoCure Ltd's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $87.53M | $342.12M | $149.62M | $127.28M | $185.42M | $164.80M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $93.27M | $85.23M | $89.92M | $84.51M | $67.06M | $64.70M |
| Inventory | $43.46M | $39.10M | $40.21M | $39.47M | $39.10M | $40.44M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.